Logo do repositório
 
Publicação

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season

2017-10-12Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorRondy, Marc
dc.contributor.authorGherasim, Alin
dc.contributor.authorCasado, Itziar
dc.contributor.authorLaunay, Odile
dc.contributor.authorRizzo, Caterina
dc.contributor.authorPitigoi, Daniela
dc.contributor.authorMickiene, Aukse
dc.contributor.authorMarbus, Sierk D
dc.contributor.authorMachado, Ausenda
dc.contributor.authorSyrjänen, Ritva K
dc.contributor.authorPem-Novose, Iva
dc.contributor.authorHorváth, Judith Krisztina
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorCastilla, Jesús
dc.contributor.authorVanhems, Philippe
dc.contributor.authorAlfonsi, Valeria
dc.contributor.authorIvanciuc, Alina E
dc.contributor.authorKuliese, Monika
dc.contributor.authorvan Gageldonk-Lafeber, Rianne
dc.contributor.authorGomez, Veronica
dc.contributor.authorIkonen, Niina
dc.contributor.authorLovric, Zvjezdana
dc.contributor.authorFerenczi, Annamária
dc.contributor.authorMoren, Alain
dc.contributor.authorI-MOVE+ hospital working group
dc.date.accessioned2018-02-26T15:59:04Z
dc.date.available2018-02-26T15:59:04Z
dc.date.issued2017-10-12
dc.descriptionMembers of the I-Move+hospital working group - Portugal: B. Nunes, I. Kislaya, A.P. Rodrigues (National Health Institute Doutor Ricardo Jorge, Lisbon), V. Gomes, R. Côrte-Real (Centro Hospitalar de Lisboa Central, Lisbon), J. Poças, M.J. Peres (Centro Hospitalar de Setúbal, Setúbal).pt_PT
dc.description.abstractIn a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65-79-year-olds and 13% (95% CI: -15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.pt_PT
dc.description.sponsorshipFunding: The I-MOVE+ project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446. The Lithuanian I-MOVE+ study sites were supported by a grant from the Research Council of Lithuania (SEN-03/2015).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEuro Surveill. 2017 Oct;22(41):1-6. doi: 10.2807/1560-7917.ES.2017.22.41.17-00645pt_PT
dc.identifier.doi10.2807/1560-7917.ES.2017.22.41.17-00645pt_PT
dc.identifier.issn1025-496X
dc.identifier.urihttp://hdl.handle.net/10400.18/5071
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Centre for Disease Prevention and Controlpt_PT
dc.relationI-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
dc.relation.publisherversionhttp://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.41.17-00645pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectA(H3N2)pt_PT
dc.subjectInfluenzapt_PT
dc.subjectCases Control;pt_PT
dc.subjectElderlypt_PT
dc.subjectHospitalisationpt_PT
dc.subjectVaccine Effectivenesspt_PT
dc.subjectVacina Antigripalpt_PT
dc.subjectCuidados de Saúdept_PT
dc.subjectEfetividade da Vacina Antigripalpt_PT
dc.titleLow 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasonpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleI-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/634446/EU
oaire.citation.endPage6pt_PT
oaire.citation.issue41pt_PT
oaire.citation.startPage1pt_PT
oaire.citation.titleEurosurveillancept_PT
oaire.citation.volume22pt_PT
oaire.fundingStreamH2020
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublicationccfd73a6-6f3c-4702-956c-544973bca97d
relation.isProjectOfPublication.latestForDiscoveryccfd73a6-6f3c-4702-956c-544973bca97d

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
Rondy_Low 2016_17 season vaccine effectiveness against influenza.pdf
Tamanho:
122.84 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

DEP - Artigos em revistas internacionais